All terms in EFO
| Label | Id | Description |
|---|---|---|
| Cryptomicrotia - brachydactyly - excess fingertip arch | Orphanet_1547 | [Cryptomicrotia - brachydactyly - excess fingertip arch syndrome describes a combination of malformations that include bilateral cryptomicrotia, brachytelomesophalangy with short middle and distal phalanges of digits 2 through 5, hypoplastic toenails and excess fingertip arch patterns, and has been reported in one family (mother and son). Cryptomicrotia - brachydactyly - excess fingertip arch syndrome is thought to follow an autosomal dominant transmission. There have been no further descriptions in the literature since 1988.] |
| congenital adrenal hyperplasia due to 17-alpha-hydroxylase deficiency | MONDO_0008730 | [A very rare form of congenital adrenal hyperplasia (CAH) characterized by glucocorticoid deficiency, hypergonadotrophic hypogonadism and severe hypokalemic hypertension.] |
| 3-phosphoinositide-dependent protein kinase 1 measurement | EFO_0020116 | [The determination of the amount of 3-phosphoinositide-dependent protein kinase 1 in a sample] |
| Crisponi syndrome | Orphanet_1545 | |
| Cold-induced sweating syndrome-hyperthermia spectrum | Orphanet_401993 | |
| 40s ribosomal protein S3 measurement | EFO_0020117 | [The determination of the amount of 40s ribosomal protein S3 in a sample] |
| age of onset of glaucoma | OBA_2040154 | [The age at which glaucoma manifestations first appear.] |
| 40s ribosomal protein S7 measurement | EFO_0020118 | [The determination of the amount of 40s ribosomal protein S7 in a sample] |
| age of onset of stroke disorder | OBA_2040155 | [The age at which stroke disorder manifestations first appear.] |
| 40s ribosomal protein SA measurement | EFO_0020119 | [The determination of the amount of 40s ribosomal protein SA in a sample] |
| age of onset of coronary stenosis | OBA_2040156 | [The age at which coronary stenosis manifestations first appear.] |
| apolipoprotein D measurement | EFO_0020156 | [The determination of the amount of apolipoprotein D in a sample] |
| apolipoprotein E (isoform E3) measurement | EFO_0020157 | [The determination of the amount of apolipoprotein E (isoform E3) in a sample] |
| Pathologic fracture | HP_0002756 | [A pathologic fracture occurs when a bone breaks in an area that is weakened secondarily to another disease process such as tumor, infection, and certain inherited bone disorders. A pathologic fracture can occur without a degree of trauma required to cause fracture in healthy bone.] |
| Increased susceptibility to fractures | HP_0002659 | [An abnormally increased tendency to fractures of bones caused by an abnormal reduction in bone strength that is generally associated with an increased risk of fracture.] |
| apolipoprotein E (isoform E4) measurement | EFO_0020158 | [The determination of the amount of apolipoprotein E (isoform E4) in a sample] |
| apoptosis regulator BCL-2 measurement | EFO_0020159 | [The determination of the amount of apoptosis regulator BCL-2 in a sample] |
| Delayed skeletal maturation | HP_0002750 | [A decreased rate of skeletal maturation. Delayed skeletal maturation can be diagnosed on the basis of an estimation of the bone age from radiographs of specific bones in the human body.] |
| anterior gradient protein 2 homolog measurement | EFO_0020152 | [The determination of the amount of anterior gradient protein 2 homolog in a sample] |
| anti-muellerian hormone type-2 receptor measurement | EFO_0020153 | [The determination of the amount of anti-muellerian hormone type-2 receptor in a sample] |